Real Estate Aktie
WKN DE: A0ES5S / ISIN: AU000000RNC6
|
23.12.2025 18:07:04
|
Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears
On November 14, New York City-based Suvretta Capital Management disclosed a buy of 387,641 shares of Mineralys Therapeutics (NASDAQ:MLYS) that contributed to an overall position increase of about $57.25 million.Suvretta Capital Management, a U.S.-based investment adviser, reported in a November 14 SEC filing that it increased its stake in Mineralys Therapeutics (NASDAQ:MLYS) during the third quarter. The fund acquired 387,641 additional shares, bringing total holdings to 2.13 million shares worth $80.85 million as of September 30. The fund reported 93 total positions for the quarter.This buy brings the fund’s MLYS stake to 2.07% of 13F AUM after the third-quarter increase.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!